Epidemiology of ovarian cancer

Methods in Molecular Biology

Volumn 472, Issue , 2009, Pages 413-437

  Permuth Wey, Jennifer ^a   Sellers, Thomas A ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Epidemiology; Histology; Ovarian cancer; Reproductive history; Risk factors

Indexed keywords

CLASSIFICATION; FEMALE; HUMAN; OVARY TUMOR; PATHOLOGY; REVIEW; RISK FACTOR; UNITED STATES;

FEMALE; HUMANS; OVARIAN NEOPLASMS; RISK FACTORS; UNITED STATES;

EID: 58149465743     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-492-0_20     Document Type: Review

References (183)

1. Ferlay J., Bray F., Pisani P. and Parkin D.M. (2004) GLOBOCAN 2002: Cancer Incidence, Mortality, and Prevalence Worldwide IARC CancerBase No. 5. version 2.0, IARC Press, Lyon, France. http://www-dep.iarc.fr/.
2. Sankaranarayanan, R., and Ferlay, J. (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20, 207-225
3. American Cancer Society. Cancer Facts and Figures 2006. Atlanta: American Cancer Society, 2006.
4. Ries, L. A. G., Harkins, D., Krapcho, M., Mariotto, A., Miller, B. A., Feuer, E. S., Clegg, L., Horner, M. J., Howlader, N., Eisner, M. P., Richman, M., Edwards, B. K. (eds). SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Bethesa, MD, http://seer.cancer.gov/csr/1975-2004/, based on November 2006 SEER data submission, posted to the SEER website 2007.
5. Chen, V. W., Ruiz, B., Killeen, J. L., Cote, T. R., Wu, X. C., and Correa, C. N. (2003) Pathology and classification of ovarian tumors. Cancer 97, 2631-2642
6. Weiss, N. S., Cook, L. S., Farrow, D. C., Rosenblatt, K. A. (1996) Ovarian Cancer. In: Schottenfeld, D., Fraumeni, J. F. (eds.) Cancer Epidemiology and Prevention. Oxford University Press, New York pp. 1040-1057.
7. Averette, H.E., Nguyen, H. (1995) Gynecologic Cancer. In: Murphy GP, Lawrence L, Lenhard RE (eds) American Cancer Society Textbook of Clinical Oncology, Atlanta, pp 552-579.
8. Eltabbakh, G. H., Natarajan, N., Piver, M. S., and Mettlin, C. J. (1999) Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. Gynecol Oncol 74, 103-107.
9. Tung, K. H., Goodman, M. T., Wu, A. H., McDuffie, K., Wilkens, L. R., Kolonel, L. N., Nomura, A. M., Terada, K. Y., Carney, M. E., and Sobin, L. H. (2003) Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 158, 629-638.
10. Marchbanks, P. A., Wilson, H., Bastos, E., Cramer, D. W., Schildkraut, J. M., and Peterson, H. B. (2000) Cigarette smoking and epithelial ovarian cancer by histologic type. Obstet Gynecol 95, 255-260.
11. Risch, H. A., Marrett, L. D., Jain, M., and Howe, G. R. (1996) Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol 144, 363-372.
12. Chiaffarino, F., Parazzini, F., Bosetti, C., Franceschi, S., Talamini, R., Canzonieri, V., Montella, M., Ramazzotti, V., Franceschi, S., and La Vecchia, C. (2007) Risk factors for ovarian cancer histotypes. Eur J Cancer 43, 1208-1213.
13. Kurian, A. W., Balise, R. R., McGuire, V., and Whittemore, A. S. (2005) Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 96, 520-530.
14. Parazzini, F., Chiaffarino, F., Negri, E., Surace, M., Benzi, G., Franceschi, S., Fedele, L., and La Vecchia, C. (2004) Risk factors for different histological types of ovarian cancer. Int J Gynecol Cancer 14, 431-436.
15. Herrinton, L. J., Stanford, J. L., Schwartz, S. M., and Weiss, N. S. (1994) Ovarian cancer incidence among Asian migrants to the United States and their descendants. J Natl Cancer Inst 86, 1336-1339.
16. Kliewer, E. V. and Smith, K. R. (1995) Ovarian cancer mortality among immigrants in Australia and Canada. Cancer Epidemiol Biomarkers Prev 4, 453-458.
17. Bray, F., Loos, A. H., Tognazzo, S., and La Vecchia, C. (2005) Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer 113, 977-990.
18. Coleman, M. P., Esteve, J., Damiecki, P., Arslan, A., and Renard, H. (1993) Trends in cancer incidence and mortality. IARC Sci Publ, 1-806.
19. Howe, H. L., Wu, X., Ries, L. A., Cokkinides, V., Ahmed, F., Jemal, A., Miller, B., Williams, M., Ward, E., Wingo, P. A., Ramirez, A., and Edwards, B. K. (2006) Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107, 1711-1742.
20. Parazzini, F., Franceschi, S., La Vecchia, C., and Fasoli, M. (1991) The epidemiology of ovarian cancer. Gynecol Oncol 43, 9-23.
21. La Vecchia, C. (2001) Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev 10, 125-129.
22. Barnholtz-Sloan, J. S., Schwartz, A. G., Qureshi, F., Jacques, S., Malone, J., and Munkarah, A. R. (2003) Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol 189, 1120-1127.
23. Nguyen, H. N., Averette, H. E., and Janicek, M. (1994) Ovarian carcinoma. A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention. Cancer 74, 545-555.
24. Parazzini, F., Negri, E., La Vecchia, C., Restelli, C., and Franceschi, S. (1992) Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study. Am J Epidemiol 135, 35-40.
25. Stratton, J. F., Pharoah, P., Smith, S. K., Easton, D., and Ponder, B. A. (1998) A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 105, 493-499.
26. Sutcliffe, S., Pharoah, P. D., Easton, D. F., and Ponder, B. A. (2000) Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer. Int J Cancer 87, 110-117.
27. Ziogas, A., Gildea, M., Cohen, P., Bringman, D., Taylor, T. H., Seminara, D., Barker, D., Casey, G., Haile, R., Liao, S. Y., Thomas, D., Noble, B., Kurosaki, T., and Anton-Culver, H. (2000) Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 9, 103-111.
28. Negri, E., Pelucchi, C., Franceschi, S., Montella, M., Conti, E., Dal Maso, L., Parazzini, F., Tavani, A., Carbone, A., and La Vecchia, C. (2003) Family history of cancer and risk of ovarian cancer. Eur J Cancer 39, 505-510.
29. Frank, T. S., Manley, S. A., Olopade, O. I., Cummings, S., Garber, J. E., Bernhardt, B., Antman, K., Russo, D., Wood, M. E., Mullineau, L., Isaacs, C., Peshkin, B., Buys, S., Venne, V., Rowley, P. T., Loader, S., Offit, K., Robson, M., Hampel, H., Brener, D., Winer, E. P., Clark, S., Weber, B., Strong, L. C., Thomas, A., et al. (1998) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16, 2417-2425.
30. Narod, S., Ford, D., Devilee, P., Barkardottir, R. B., Eyfjord, J., Lenoir, G., Serova, O., Easton, D., and Goldgar, D. (1995) Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium. Am J Hum Genet 57, 957-958.
31. Ford, D., Easton, D. F., Bishop, D. T., Narod, S. A., and Goldgar, D. E. (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343, 692-695.
32. Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, A., Pasini, B., Radice, P., Manoukian, S., Eccles, D. M., Tang, N., Olah, E., Anton-Culver, H., Warner, E., Lubinski, J., Gronwald, J., Gorski, B., Tulinius, H., Thorlacius, S., Eerola, H., Nevanlinna, H., Syrjakoski, K., Kallioniemi, O. P., Thompson, D., Evans, C., Peto, J., Lalloo, F., Evans, D. G., and Easton, D. F. (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72, 1117-1130.
33. Malander, S., Ridderheim, M., Masback, A., Loman, N., Kristoffersson, U., Olsson, H., Nilbert, M., and Borg, A. (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40, 422-428.
34. Menkiszak, J., Gronwald, J., Gorski, B., Jakubowska, A., Huzarski, T., Byrski, T., Foszczynska-Kloda, M., Haus, O., Janiszewska, H., Perkowska, M., Brozek, I., Grzybowska, E., Zientek, H., Gozdz, S., Kozak-Klonowska, B., Urbanski, K., Miturski, R., Kowalczyk, J., Pluzanska, A., Niepsuj, S., Koc, J., Szwiec, M., Drosik, K., Mackiewicz, A., Lamperska, K., Strozyk, E., Godlewski, D., Stawicka, M., Wasko, B., Bebenek, M., Rozmiarek, A., Rzepka-Gorska, I., Narod, S. A., and Lubinski, J. (2003) Hereditary ovarian cancer in Poland. Int J Cancer 106, 942-945.
35. Pal, T., Permuth-Wey, J., Betts, J. A., Krischer, J. P., Fiorica, J., Arango, H., LaPolla, J., Hoffman, M., Martino, M. A., Wakeley, K., Wilbanks, G., Nicosia, S., Cantor, A., and Sutphen, R. (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104, 2807-2816.
36. Risch, H. A., McLaughlin, J. R., Cole, D. E., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L., Fan, I., Wong, B., and Narod, S. A. (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68, 700-710.
37. Stratton, J. F., Gayther, S. A., Russell, P., Dearden, J., Gore, M., Blake, P., Easton, D., and Ponder, B. A. (1997) Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336, 1125-1130.
38. Takahashi, H., Behbakht, K., McGovern, P. E., Chiu, H. C., Couch, F. J., Weber, B. L., Friedman, L. S., King, M. C., Furusato, M., LiVolsi, V. A., and et al. (1995) Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55, 2998-3002.
39. Anton-Culver, H., Cohen, P. F., Gildea, M. E., and Ziogas, A. (2000) Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer. Eur J Cancer 36, 1200-1208.
40. Bjorge, T., Lie, A. K., Hovig, E., Gislefoss, R. E., Hansen, S., Jellum, E., Langseth, H., Nustad, K., Trope, C. G., and Dorum, A. (2004) BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. Br J Cancer 91, 1829-1834.
41. Van Der Looij, M., Szabo, C., Besznyak, I., Liszka, G., Csokay, B., Pulay, T., Toth, J., Devilee, P., King, M. C., and Olah, E. (2000) Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer 86, 737-740.
42. Lynch, H. T. and Smyrk, T. (1996) Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 78, 1149-1167.
43. Marra, G., and Boland, C. R. (1995) Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87, 1114-1125.
44. Malander, S., Rambech, E., Kristoffersson, U., Halvarsson, B., Ridderheim, M., Borg, A., and Nilbert, M. (2006) The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer. Gynecol Oncol 101, 238-243.
45. Aarnio, M., Mecklin, J. P., Aaltonen, L. A., Nystrom-Lahti, M., and Jarvinen, H. J. (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64, 430-433.
46. Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltomaki, P., Mecklin, J. P., and Jarvinen, H. J. (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81, 214-218.
47. Prat, J., Ribe, A., and Gallardo, A. (2005) Hereditary ovarian cancer. Hum Pathol 36, 861-870.
48. Boyd, J. and Rubin, S. C. (1997) Hereditary ovarian cancer: molecular genetics and clinical implications. Gynecol Oncol 64, 196-206.
49. Lynch, H. T., Casey, M. J., Shaw, T. G., and Lynch, J. F. (1998) Hereditary factors in gynecologic cancer. Oncologist 3, 319-338.
50. Risch, H. A. (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90, 1774-1786.
51. Casagrande, J. T., Louie, E. W., Pike, M. C., Roy, S., Ross, R. K., and Henderson, B. E. (1979) "Incessant ovulation" and ovarian cancer. Lancet 2, 170-173.
52. Cramer, D. W. and Welch, W. R. (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71, 717-721.
53. Riman, T., Persson, I., and Nilsson, S. (1998) Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf) 49, 695-707.
54. Booth, M., Beral, V., and Smith, P. (1989) Risk factors for ovarian cancer: a case-control study. Br J Cancer 60, 592-598.
55. Franceschi, S., La Vecchia, C., Booth, M., Tzonou, A., Negri, E., Parazzini, F., Trichopoulos, D., and Beral, V. (1991) Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. Int J Cancer 49, 57-60.
56. Parazzini, F., La Vecchia, C., Negri, E., and Gentile, A. (1989) Menstrual factors and the risk of epithelial ovarian cancer. J Clin Epidemiol 42, 443-448.
57. Purdie, D., Green, A., Bain, C., Siskind, V., Ward, B., Hacker, N., Quinn, M., Wright, G., Russell, P., and Susil, B. (1995) Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women' Health Study Group. Int J Cancer 62, 678-684.
58. Tavani, A., Negri, E., Franceschi, S., Parazzini, F., and La Vecchia, C. (1993) Risk factors for epithelial ovarian cancer in women under age 45. Eur J Cancer 29A, 1297-1301.
59. Whittemore, A. S., Harris, R., and Itnyre, J. (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136, 1184-1203.
60. Wu, M. L., Whittemore, A. S., Paffenbarger, R. S., Jr., Sarles, D. L., Kampert, J. B., Grosser, S., Jung, D. L., Ballon, S., Hendrickson, M., and Mohle-Boetani, J. (1988) Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. Am J Epidemiol 128, 1216-1227.
61. Wynder, E. L., Dodo, H., and Barber, H. R. (1969) Epidemiology of cancer of the ovary. Cancer 23, 352-370.
62. Hankinson, S. E., Colditz, G. A., Hunter, D. J., Willett, W. C., Stampfer, M. J., Rosner, B., Hennekens, C. H., and Speizer, F. E. (1995) A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer 76, 284-290.
63. Risch, H. A., Marrett, L. D., and Howe, G. R. (1994) Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 140, 585-597.
64. Shu, X. O., Brinton, L. A., Gao, Y. T., and Yuan, J. M. (1989) Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 49, 3670-3674.
65. Tzonou, A., Day, N. E., Trichopoulos, D., Walker, A., Saliaraki, M., Papapostolou, M., and Polychronopoulou, A. (1984) The epidemiology of ovarian cancer in Greece: a case-control study. Eur J Cancer Clin Oncol 20, 1045-1052.
66. Kvale, G., Heuch, I., Nilssen, S., and Beral, V. (1988) Reproductive factors and risk of ovarian cancer: a prospective study. Int J Cancer 42, 246-251.
67. McGowan, L., Norris, H. J., Hartge, P., Hoover, R., and Lesher, L. (1988) Risk factors in ovarian cancer. Eur J Gynaecol Oncol 9, 195-199.
68. Newhouse, M. L., Pearson, R. M., Fullerton, J. M., Boesen, E. A., and Shannon, H. S. (1977) A case control study of carcinoma of the ovary. Br J Prev Soc Med 31, 148-153.
69. Polychronopoulou, A., Tzonou, A., Hsieh, C. C., Kaprinis, G., Rebelakos, A., Toupadaki, N., and Trichopoulos, D. (1993) Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. Int J Cancer 55, 402-407.
70. Annegers, J. F., Strom, H., Decker, D. G., Dockerty, M. B., and O'Fallon, W. M. (1979) Ovarian cancer: incidence and case-control study. Cancer 43, 723-729.
71. Cramer, D. W., Hutchison, G. B., Welch, W. R., Scully, R. E., and Ryan, K. J. (1983) Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst 71, 711-716.
72. Hartge, P., Hoover, R., McGowan, L., Lesher, L., and Norris, H. J. (1988) Menopause and ovarian cancer. Am J Epidemiol 127, 990-998.
73. Domchek, S. M. and Rebbeck, T. R. (2007) Prophylactic oophorectomy in women at increased cancer risk. Curr Opin Obstet Gynecol 19, 27-30.
74. Green, A., Purdie, D., Bain, C., Siskind, V., Russell, P., Quinn, M., and Ward, B. (1997) Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women' Health Study Group. Int J Cancer 71, 948-951.
75. Hankinson, S. E., Hunter, D. J., Colditz, G. A., Willett, W. C., Stampfer, M. J., Rosner, B., Hennekens, C. H., and Speizer, F. E. (1993) Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA 270, 2813-2818.
76. Kreiger, N., Sloan, M., Cotterchio, M., and Parsons, P. (1997) Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol 26, 710-715.
77. Miracle-McMahill, H. L., Calle, E. E., Kosinski, A. S., Rodriguez, C., Wingo, P. A., Thun, M. J., and Heath, C. W., Jr. (1997) Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am J Epidemiol 145, 349-357.
78. Rosenblatt, K. A. and Thomas, D. B. (1996) Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev 5, 933-935.
79. Weiss, N. S. and Harlow, B. L. (1986) Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer? Am J Epidemiol 124, 856-858.
80. Chiaffarino, F., Parazzini, F., Decarli, A., Franceschi, S., Talamini, R., Montella, M., and La Vecchia, C. (2005) Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer. Gynecol Oncol 97, 318-322.
81. Huncharek, M., Geschwind, J. F., and Kupelnick, B. (2003) Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11,933 subjects from sixteen observational studies. Anticancer Res 23, 1955-1960.
82. Risch, H. A. and Howe, G. R. (1995) Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 4, 447-451.
83. Joly, D. J., Lilienfeld, A. M., Diamond, E. L., and Bross, I. D. (1974) An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am J Epidemiol 99, 190-209.
84. (1987) Centers for Disease Control Cancer and Steroid Hormone Study. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med 316, 650-655.
85. Hartge, P., Schiffman, M. H., Hoover, R., McGowan, L., Lesher, L., and Norris, H. J. (1989) A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 161, 10-16.
86. Nasca, P. C., Greenwald, P., Chorost, S., Richart, R., and Caputo, T. (1984) An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 119, 705-713.
87. Adami, H. O., Hsieh, C. C., Lambe, M., Trichopoulos, D., Leon, D., Persson, I., Ekbom, A., and Janson, P. O. (1994) Parity, age at first childbirth, and risk of ovarian cancer. Lancet 344, 1250-1254.
88. La Vecchia, C., Decarli, A., Franceschi, S., Regallo, M., and Tognoni, G. (1984) Age at first birth and the risk of epithelial ovarian cancer. J Natl Cancer Inst 73, 663-666.
89. Negri, E., Franceschi, S., Tzonou, A., Booth, M., La Vecchia, C., Parazzini, F., Beral, V., Boyle, P., and Trichopoulos, D. (1991) Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer. Int J Cancer 49, 50-56.
90. Franceschi, S., La Vecchia, C., Helmrich, S. P., Mangioni, C., and Tognoni, G. (1982) Risk factors for epithelial ovarian cancer in Italy. Am J Epidemiol 115, 714-719.
91. Hildreth, N. G., Kelsey, J. L., LiVolsi, V. A., Fischer, D. B., Holford, T. R., Mostow, E. D., Schwartz, P. E., and White, C. (1981) An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 114, 398-405.
92. John, E. M., Whittemore, A. S., Harris, R., and Itnyre, J. (1993) Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group. J Natl Cancer Inst 85 142-147.
93. Chen, M. T., Cook, L. S., Daling, J. R., and Weiss, N. S. (1996) Incomplete pregnancies and risk of ovarian cancer (Washington, United States). Cancer Causes Control 7, 415-420.
94. Mori, M., Harabuchi, I., Miyake, H., Casagrande, J. T., Henderson, B. E., and Ross, R. K. (1988) Reproductive, genetic, and dietary risk factors for ovarian cancer. Am J Epidemiol 128, 771-777.
95. Negri, E., Franceschi, S., La Vecchia, C., and Parazzini, F. (1992) Incomplete pregnancies and ovarian cancer risk. Gynecol Oncol 47, 234-238.
96. Mosgaard, B. J., Lidegaard, O., Kjaer, S. K., Schou, G., and Andersen, A. N. (1997) Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 67, 1005-1012.
97. Modan, B., Ron, E., Lerner-Geva, L., Blumstein, T., Menczer, J., Rabinovici, J., Oelsner, G., Freedman, L., Mashiach, S., and Lunenfeld, B. (1998) Cancer incidence in a cohort of infertile women. Am J Epidemiol 147, 1038-1042.
98. Franceschi, S., La Vecchia, C., Negri, E., Guarneri, S., Montella, M., Conti, E., and Parazzini, F. (1994) Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 9, 1673-1675.
99. Brinton, L. A., Sakoda, L. C., Sherman, M. E., Frederiksen, K., Kjaer, S. K., Graubard, B. I., Olsen, J. H., and Mellemkjaer, L. (2005) Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev 14, 2929-2935.
100. Edmondson, R. J. and Monaghan, J. M. (2001) The epidemiology of ovarian cancer. Int J Gynecol Cancer 11, 423-429.
101. Vigano, P., Somigliana, E., Parazzini, F., and Vercellini, P. (2007) Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer. Fertil Steril 88, 588-593.
102. Schildkraut, J. M., Schwingl, P. J., Bastos, E., Evanoff, A., and Hughes, C. (1996) Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 88, 554-559.
103. Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., and Self, S. G. (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331, 771-776.
104. Ness, R. B., Cramer, D. W., Goodman, M. T., Kjaer, S. K., Mallin, K., Mosgaard, B. J., Purdie, D. M., Risch, H. A., Vergona, R., and Wu, A. H. (2002) Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 155, 217-224.
105. Potashnik, G., Lerner-Geva, L., Genkin, L., Chetrit, A., Lunenfeld, E., and Porath, A. (1999) Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 71, 853-859.
106. Venn, A., Watson, L., Lumley, J., Giles, G., King, C., and Healy, D. (1995) Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 346, 995-1000.
107. Ayhan, A., Salman, M. C., Celik, H., Dursun, P., Ozyuncu, O., and Gultekin, M. (2004) Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers. Acta Obstet Gynecol Scand 83, 1104-1111.
108. Gwinn, M. L., Lee, N. C., Rhodes, P. H., Layde, P. M., and Rubin, G. L. (1990) Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 43, 559-568.
109. Rosenblatt, K. A. and Thomas, D. B. (1993) Lactation and the risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Epidemiol 22, 192-197.
110. Schneider, A. P., 2nd (1987) Risk factor for ovarian cancer. N Engl J Med 317, 508-509.
111. Gerstman, B. B., Gross, T. P., Kennedy, D. L., Bennett, R. C., Tomita, D. K., and Stadel, B. V. (1991) Trends in the content and use of oral contraceptives in the United States, 1964-88. Am J Public Health 81, 90-96.
112. Franceschi, S., Parazzini, F., Negri, E., Booth, M., La Vecchia, C., Beral, V., Tzonou, A., and Trichopoulos, D. (1991) Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use. Int J Cancer 49, 61-65.
113. La Vecchia, C. and Franceschi, S. (1999) Oral contraceptives and ovarian cancer. Eur J Cancer Prev 8, 297-304.
114. Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Lewis, J. L., Jr., Strom, B. L., Harlap, S., and Shapiro, S. (1994) A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 139, 654-661.
115. Vessey, M. and Painter, R. (2006) Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004. Br J Cancer 95, 385-389.
116. La Vecchia, C. (2006) Estrogen-progestogen replacement therapy and ovarian cancer: an update. Eur J Cancer Prev 15, 490-492.
117. (1989) Epithelial ovarian cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Epidemiol 18, 538-545.
118. Beral, V., Hannaford, P., and Kay, C. (1988) Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study. Lancet 2, 1331-1335.
119. La Vecchia, C., Altieri, A., Franceschi, S., and Tavani, A. (2001) Oral contraceptives and cancer: an update. Drug Saf 24, 741-754.
120. Rosenblatt, K. A., Thomas, D. B., and Noonan, E. A. (1992) High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Eur J Cancer 28A, 1872-1876.
121. Ness, R. B., Grisso, J. A., Klapper, J., Schlesselman, J. J., Silberzweig, S., Vergona, R., Morgan, M., and Wheeler, J. E. (2000) Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions. Am J Epidemiol 152, 233-241.
122. La Vecchia, C. (2006) Oral contraceptives and ovarian cancer: an update, 1998-2004. Eur J Cancer Prev 15, 117-124.
123. Riman, T., Dickman, P. W., Nilsson, S., Correia, N., Nordlinder, H., Magnusson, C. M., and Persson, I. R. (2002) Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Am J Epidemiol 156, 363-373.
124. Liang, A. P., Levenson, A. G., Layde, P. M., Shelton, J. D., Hatcher, R. A., Potts, M., and Michelson, M. J. (1983) Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections. JAMA 249, 2909-2912.
125. Wingo, P. A., Cardinez, C. J., Landis, S. H., Greenlee, R. T., Ries, L. A., Anderson, R. N., and Thun, M. J. (2003) Long-term trends in cancer mortality in the United States, 1930-1998. Cancer 97, 3133-3275.
126. Mathur, R. S., Landgrebe, S. C., Moody, L. O., Semmens, J. P., and Williamson, H. O. (1985) The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. Maturitas 7, 129-133.
127. Fraser, I. S. (1998) Estrogens and progestogens in clinical practice, New York, London.
128. Riman, T., Dickman, P. W., Nilsson, S., Correia, N., Nordlinder, H., Magnusson, C. M., Weiderpass, E., and Persson, I. R. (2002) Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 94, 497-504.
129. Weiss, N. S., Lyon, J. L., Krishnamurthy, S., Dietert, S. E., Liff, J. M., and Daling, J. R. (1982) Noncontraceptive estrogen use and the occurrence of ovarian cancer. J Natl Cancer Inst 68, 95-98.
130. Coughlin, S. S., Giustozzi, A., Smith, S. J., and Lee, N. C. (2000) A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer. J Clin Epidemiol 53, 367-375.
131. Garg, P. P., Kerlikowske, K., Subak, L., and Grady, D. (1998) Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 92, 472-479.
132. Kaufman, D. W., Kelly, J. P., Welch, W. R., Rosenberg, L., Stolley, P. D., Warshauer, M. E., Lewis, J., Woodruff, J., and Shapiro, S. (1989) Noncontraceptive estrogen use and epithelial ovarian cancer. Am J Epidemiol 130, 1142-1151.
133. Folsom, A. R., Anderson, J. P., and Ross, J. A. (2004) Estrogen replacement therapy and ovarian cancer. Epidemiology 15, 100-104.
134. Lacey, J. V., Jr., Brinton, L. A., Leitzmann, M. F., Mouw, T., Hollenbeck, A., Schatzkin, A., and Hartge, P. (2006) Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. J Natl Cancer Inst 98, 1397-1405.
135. Lacey, J. V., Jr., Mink, P. J., Lubin, J. H., Sherman, M. E., Troisi, R., Hartge, P., Schatzkin, A., and Schairer, C. (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288, 334-341.
136. Rodriguez, C., Patel, A. V., Calle, E. E., Jacob, E. J., and Thun, M. J. (2001) Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA 285, 1460-1465.
137. Lacey, J. V., Jr., Leitzmann, M., Brinton, L. A., Lubin, J. H., Sherman, M. E., Schatzkin, A., and Schairer, C. (2006) Weight, height, and body mass index and risk for ovarian cancer in a cohort study. Ann Epidemiol 16, 869-876.
138. Anderson, G. L., Judd, H. L., Kaunitz, A. M., Barad, D. H., Beresford, S. A., Pettinger, M., Liu, J., McNeeley, S. G., and Lopez, A. M. (2003) Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women' Health Initiative randomized trial. JAMA 290, 1739-1748.
139. Danforth, K. N., Tworoger, S. S., Hecht, J. L., Rosner, B. A., Colditz, G. A., and Hankinson, S. E. (2007) A prospective study of postmenopausal hormone use and ovarian cancer risk. Br J Cancer 96, 151-156.
140. Beral, V., Bull, D., Green, J., and Reeves, G. (2007) Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 369, 1703-1710.
141. Risch, H. A. (1996) Estrogen replacement therapy and risk of epithelial ovarian cancer. Gynecol Oncol 63, 254-257.
142. Kumar, V. and Robbins, S. L. (2007) Robbins basic pathology, Saunders/Elsevier, Philadelphia, PA.
143. Rodriguez, C., Calle, E. E., Fakhrabadi-Shokoohi, D., Jacobs, E. J., and Thun, M. J. (2002) Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 11, 822-828.
144. Lubin, F., Chetrit, A., Freedman, L. S., Alfandary, E., Fishler, Y., Nitzan, H., Zultan, A., and Modan, B. (2003) Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol 157, 113-120.
145. Farrow, D. C., Weiss, N. S., Lyon, J. L., and Daling, J. R. (1989) Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol 129, 1300-1304.
146. Purdie, D. M., Bain, C. J., Webb, P. M., Whiteman, D. C., Pirozzo, S., and Green, A. C. (2001) Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control 12, 855-863.
147. Anderson, J. P., Ross, J. A., and Folsom, A. R. (2004) Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women' Health Study. Cancer 100, 1515-1521.
148. Engeland, A., Tretli, S., and Bjorge, T. (2003) Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 95, 1244-1248.
149. Fairfield, K. M., Willett, W. C., Rosner, B. A., Manson, J. E., Speizer, F. E., and Hankinson, S. E. (2002) Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100, 288-296.
150. Hirose, K., Tajima, K., Hamajima, N., Kuroishi, T., Kuzuya, K., Miura, S., and Tokudome, S. (1999) Comparative case-referent study of risk factors among hormone-related female cancers in Japan. Jpn J Cancer Res 90, 255-261.
151. Lukanova, A., Toniolo, P., Lundin, E., Micheli, A., Akhmedkhanov, A., Muti, P., Zeleniuch-Jacquotte, A., Biessy, C., Lenner, P., Krogh, V., Berrino, F., Hallmans, G., Riboli, E., and Kaaks, R. (2002) Body mass index in relation to ovarian cancer: a multi-centre nested case-control study. Int J Cancer 99, 603-608.
152. Schouten, L. J., Goldbohm, R. A., and van den Brandt, P. A. (2003) Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 157, 424-433.
153. Beehler, G. P., Sekhon, M., Baker, J. A., Teter, B. E., McCann, S. E., Rodabaugh, K. J., and Moysich, K. B. (2006) Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr 136, 2881-2886.
154. Olsen, C. M., Green, A. C., Whiteman, D. C., Sadeghi, S., Kolahdooz, F., and Webb, P. M. (2007) Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 43, 690-709.
155. Mink, P. J., Folsom, A. R., Sellers, T. A., and Kushi, L. H. (1996) Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: a follow-up study of older women. Epidemiology 7, 38-45.
156. Folsom, A. R., Kushi, L. H., Anderson, K. E., Mink, P. J., Olson, J. E., Hong, C. P., Sellers, T. A., Lazovich, D., and Prineas, R. J. (2000) Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women' Health Study. Arch Intern Med 160, 2117-2128.
157. Schulz, M., Lahmann, P. H., Riboli, E., and Boeing, H. (2004) Dietary determinants of epithelial ovarian cancer: a review of the epidemiologic literature. Nutr Cancer 50, 120-140.
158. Larsson, S. C., Giovannucci, E., and Wolk, A. (2004) Dietary folate intake and incidence of ovarian cancer: the Swedish Mammography Cohort. J Natl Cancer Inst 96, 396-402.
159. Larsson, S. C. and Wolk, A. (2005) Coffee consumption is not associated with ovarian cancer incidence. Cancer Epidemiol Biomarkers Prev 14, 2273-2274.
160. Riman, T., Dickman, P. W., Nilsson, S., Nordlinder, H., Magnusson, C. M., and Persson, I. R. (2004) Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol 19, 1011-1019.
161. Baker, J. A., Boakye, K., McCann, S. E., Beehler, G. P., Rodabaugh, K. J., Villella, J. A., and Moysich, K. B. (2007) Consumption of black tea or coffee and risk of ovarian cancer. Int J Gynecol Cancer 17, 50-54.
162. Whittemore, A. S., Wu, M. L., Paffenbarger, R. S., Jr., Sarles, D. L., Kampert, J. B., Grosser, S., Jung, D. L., Ballon, S., and Hendrickson, M. (1988) Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am J Epidemiol 128, 1228-1240.
163. Cottreau, C. M., Ness, R. B., and Kriska, A. M. (2000) Physical activity and reduced risk of ovarian cancer. Obstet Gynecol 96, 609-614.
164. Tavani, A., Gallus, S., La Vecchia, C., Dal Maso, L., Negri, E., Pelucchi, C., Montella, M., Conti, E., Carbone, A., and Franceschi, S. (2001) Physical activity and risk of ovarian cancer: an Italian case-control study. Int J Cancer 91, 407-411.
165. Weiderpass, E., Margolis, K. L., Sandin, S., Braaten, T., Kumle, M., Adami, H. O., and Lund, E. (2006) Prospective study of physical activity in different periods of life and the risk of ovarian cancer. Int J Cancer 118, 3153-3160.
166. Patel, A. V., Rodriguez, C., Pavluck, A. L., Thun, M. J., and Calle, E. E. (2006) Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women. Am J Epidemiol 163, 709-716.
167. Zhang, M., Xie, X., Lee, A. H., and Binns, C. W. (2004) Sedentary behaviours and epithelial ovarian cancer risk. Cancer Causes Control 15, 83-89.
168. Franks, A. L., Lee, N. C., Kendrick, J. S., Rubin, G. L., and Layde, P. M. (1987) Cigarette smoking and the risk of epithelial ovarian cancer. Am J Epidemiol 126, 112-117.
169. Smith, E. M., Sowers, M. F., and Burns, T. L. (1984) Effects of smoking on the development of female reproductive cancers. J Natl Cancer Inst 73, 371-376.
170. Modugno, F., Ness, R. B., and Cottreau, C. M. (2002) Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer. Epidemiology 13, 467-471.
171. Jordan, S. J., Whiteman, D. C., Purdie, D. M., Green, A. C., and Webb, P. M. (2006) Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 103, 1122-1129.
172. Singletary, K. W. and Gapstur, S. M. (2001) Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 286, 2143-2151.
173. Gwinn, M. L., Webster, L. A., Lee, N. C., Layde, P. M., and Rubin, G. L. (1986) Alcohol consumption and ovarian cancer risk. Am J Epidemiol 123, 759-766.
174. Adami, H. O., McLaughlin, J. K., Hsing, A. W., Wolk, A., Ekbom, A., Holmberg, L., and Persson, I. (1992) Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control 3, 419-425.
175. Larsson, S. C. and Wolk, A. (2004) Wine consumption and epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 13, 1823; author reply 1823-1824.
176. Modugno, F., Ness, R. B., and Allen, G. O. (2003) Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer. Obstet Gynecol 102, 1336-1343.
177. Goodman, M. T. and Tung, K. H. (2003) Alcohol consumption and the risk of borderline and invasive ovarian cancer. Obstet Gynecol 101, 1221-1228.
178. Kelemen, L. E., Sellers, T. A., Vierkant, R. A., Harnack, L., and Cerhan, J. R. (2004) Association of folate and alcohol with risk of ovarian cancer in a prospective study of postmenopausal women. Cancer Causes Control 15, 1085-1093.
179. Webb, P. M., Purdie, D. M., Bain, C. J., and Green, A. C. (2004) Alcohol, wine, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 13, 592-599.
180. Peterson, N. B., Trentham-Dietz, A., Newcomb, P. A., Chen, Z., Hampton, J. M., Willett, W. C., and Egan, K. M. (2006) Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer 119, 2423-2427.
181. Chang, E. T., Canchola, A. J., Lee, V. S., Clarke, C. A., Purdie, D. M., Reynolds, P., Bernstein, L., Stram, D. O., Anton-Culver, H., Deapen, D., Mohrenweiser, H., Peel, D., Pinder, R., Ross, R. K., West, D. W., Wright, W., Ziogas, A., and Horn-Ross, P. L. (2007) Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control 18, 91-103.
182. Schouten, L. J., Zeegers, M. P., Goldbohm, R. A., and van den Brandt, P. A. (2004) Alcohol and ovarian cancer risk: results from the Netherlands Cohort Study. Cancer Causes Control 15, 201-209.
183. Genkinger, J. M., Hunter, D. J., Spiegelman, D., Anderson, K. E., Buring, J. E., Freudenheim, J. L., Goldbohm, R. A., Harnack, L., Hankinson, S. E., Larsson, S. C., Leitzmann, M., McCullough, M. L., Marshall, J., Miller, A. B., Rodriguez, C., Rohan, T. E., Schatzkin, A., Schouten, L. J., Wolk, A., Zhang, S. M., and Smith-Warner, S. A. (2006) Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer 94, 757-762.